Oral vaccination based on DNA-chitosan nanoparticles against schistosoma mansoni infection

The Scientific World Journal

Volumn 2012, Issue , 2012, Pages

  Oliveira, Carolina R ^a   Rezende, Cíntia M F ^a   Silva, Marina R ^a   Borges, Olga M ^b,c   Pêgo, Ana P ^d   Goes, Alfredo M ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d INEB INSTITUTO DE ENGENHARIA BIOMÉDICA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN; INTERLEUKIN 10; NANOPARTICLE; PLASMID DNA; DNA; DNA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNIZATION; IN VIVO STUDY; INTESTINE FLUID; MOUSE; NONHUMAN; PARTICLE SIZE; PROVOCATION TEST; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SIMULATION; STOMACH JUICE; ZETA POTENTIAL; ANIMAL; C57BL MOUSE; GENETICS; HUMAN; IMMUNOLOGY; ORAL DRUG ADMINISTRATION;

MUS; SCHISTOSOMA MANSONI; VERMES;

ADMINISTRATION, ORAL; ANIMALS; CHITOSAN; DNA; FEMALE; HUMANS; MICE; MICE, INBRED C57BL; NANOPARTICLES; SCHISTOSOMIASIS MANSONI; VACCINES, DNA;

EID: 84861034466     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/2012/938457     Document Type: Article

References (39)

1. World health organization (WHO), Schistosomiasis, F.d.i. 115, Editor. 2010
2. Van Der Werf M. J., De Vlas S. J., Brooker S., Looman C. W. N., Nagelkerke N. J. D., Habbema J. D. F., Engels D., Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa Acta Tropica 2003 86 2-3 125 139 (Pubitemid 36561364)
3. Steinmann P., Keiser J., Bos R., Tanner M., Utzinger J., Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk Lancet Infectious Diseases 2006 6 7 411 425 (Pubitemid 43949139)
4. Harder A., Chemotherapeutic approaches to schistosomes: current knowledge and outlook Parasitology Research 2002 88 5 395 397 (Pubitemid 34328084)
5. Matthews K. R., Controlling and coordinating development in vector-transmitted parasites Science 2011 331 6021 1149 1153
6. King C. H., Global health: toward the elimination of schistosomiasis New England Journal of Medicine 2009 360 2 106 109
7. Bergquist R., Prospects for schistosomiasis vaccine development TDR News 2004 71 6 7
8. Chitsulo L., Loverde P., Engels D., Schistosomiasis Nature Reviews Microbiology 2004 2 1 12 13 (Pubitemid 39490043)
9. Oliveira S. C., Fonseca C. T., Cardoso F. C., Farias L. P., Leite L. C. C., Recent advances in vaccine research against schistosomiasis in Brazil Acta Tropica 2008 108 2-3 256 262
10. Schssler P., Grevelding C. G., Kunz W., Identification of Ras, MAP kinases, and a GAP protein in Schistosoma mansoni by immunoblotting and their putative involvement in male-female interaction Parasitology 1997 115 6 629 634 (Pubitemid 28078659)
11. Loeffler I. K., Bennett J. L., A rab-related GTP-binding protein in Schistosoma mansoni Molecular and Biochemical Parasitology 1996 77 1 31 40 (Pubitemid 26186161)
12. Ledgerwood J. E., Graham B. S., DNA vaccines: a safe and efficient platform technology for responding to emerging infectious diseases Human Vaccines 2009 5 9 623 626
13. Whalen R. G., DNA vaccines for emerging infectious diseases: what if? Emerging Infectious Diseases 1996 2 3 168 175 (Pubitemid 126444983)
14. Bozkir A., Saka O. M., Chitosan nanoparticles for plasmid DNA delivery: effect of chitosan molecular structure on formulation and release characteristics Drug Delivery 2004 11 2 107 112 (Pubitemid 38437079)
15. Singla A. K., Chawla M., Chitosan: some pharmaceutical and biological aspectsan update Journal of Pharmacy and Pharmacology 2001 53 8 1047 1067 (Pubitemid 32754936)
16. Ranaldi G., Marigliano I., Vespignani I., Perozzi G., Sambuy Y., The effect of chitosan and other polycations on tight junction permeability in the human intestinal Caco-2 cell line Journal of Nutritional Biochemistry 2002 13 3 157 167 (Pubitemid 34226692)
17. Mao H. Q., Roy K., Troung-Le V. L., Janes K. A., Lin K. Y., Wang Y., August J. T., Leong K. W., Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency Journal of Controlled Release 2001 70 3 399 421 (Pubitemid 32155463)
18. Van Der Lubben I. M., Verhoef J. C., Van Aelst A. C., Borchard G., Junginger H. E., Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches Biomaterials 2001 22 7 687 694 (Pubitemid 32112293)
19. Roy K., Mao H. Q., Huang S. K., Leong K. W., Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy Nature Medicine 1999 5 4 387 391 (Pubitemid 29180575)
20. Moreira C., Oliveira H., Pires L. R., Simes S., Barbosa M. A., Pgo A. P., Improving chitosan-mediated gene transfer by the introduction of intracellular buffering moieties into the chitosan backbone Acta Biomaterialia 2009 5 8 2995 3006
21. Arca H. C., Gnbeyaz M., enel S., Chitosan-based systems for the delivery of vaccine antigens Expert Review of Vaccines 2009 8 7 937 953
22. Brugnerotto J., Lizardi J., Goycoolea F. M., Argelles-Monal W., Desbrires J., Rinaudo M., An infrared investigation in relation with chitin and chitosan characterization Polymer 2001 42 8 3569 3580
23. United States Pharmacopeia General Chapter 85Bacterial Endotoxins Test 2005
24. Smithers S. R., Terry R. J., The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms Parasitology 1965 55 4 695 700
25. Marques H. H., Zouain C. S., Torres C. B. B., Oliveira J. S., Alves J. B., Goes A. M., Protective effect and granuloma down-modulation promoted by RP44 antigen a fructose 1,6 bisphosphate aldolase of Schistosoma mansoni Immunobiology 2008 213 5 437 446 (Pubitemid 351619284)
26. Goes A. M., Rocha R. S., Gazzinelli G., Doughty B. L., Production and characterization of human monoclonal antibodies against Schistosoma mansoni Parasite Immunology 1989 11 6 695 711 (Pubitemid 20008330)
27. Schneider M. C., Aguilera X. P., da Silva Junior J. B., Ault S. K., Najera P., Martinez J., Requejo R., Nicholls R. S., Yadon Z., Silva J. C., Leanes L. F., Periago M. R., Elimination of neglected diseases in Latin America and the Caribbean: a mapping of selected diseases PLoS Neglected Tropical Diseases 2011 5 2, article e964
28. Kotton C. N., Hohmann E. L., Enteric pathogens as vaccine vectors for foreign antigen delivery Infection and Immunity 2004 72 10 5535 5547 (Pubitemid 39303661)
29. Illum L., Chitosan and its use as a pharmaceutical excipient Pharmaceutical Research 1998 15 9 1326 1331 (Pubitemid 28427917)
30. Mansouri S., Lavigne P., Corsi K., Benderdour M., Beaumont E., Fernandes J. C., Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy European Journal of Pharmaceutics and Biopharmaceutics 2004 57 1 1 8 (Pubitemid 38058799)
31. Gao H., Shi W., Freund L. B., Mechanics of receptor-mediated endocytosis Proceedings of the National Academy of Sciences of the United States of America 2005 102 27 9469 9474 (Pubitemid 40981705)
32. Chen L., Mccrate J. M., Lee J. C.-M., Li H., The role of surface charge on the uptake and biocompatibility of hydroxyapatite nanoparticles with osteoblast cells Nanotechnology 2011 22 10
33. Chen G. Z., Bennett J. L., Characterization of mevalonate-labeled lipids isolated from parasite proteins in Schistosoma mansoni Molecular and Biochemical Parasitology 1993 59 2 287 292
34. Wilson M. S., Mentink-Kane M. M., Pesce J. T., Ramalingam T. R., Thompson R., Wynn T. A., Immunopathology of schistosomiasis Immunology and Cell Biology 2007 85 2 148 154 (Pubitemid 46398720)
35. Hesse M., Piccirillo C. A., Belkaid Y., Prufer J., Mentink-Kane M., Leusink M., Cheever A. W., Shevach E. M., Wynn T. A., The pathogenesis of Schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells Journal of Immunology 2004 172 5 3157 3166 (Pubitemid 38263706)
36. Wynn T. A., Cheever A. W., Williams M. E., Hieny S., Caspar P., Khn R., Mller W., Sher A., IL-10 regulates liver pathology in acute murine Schistosomiasis mansoni but is not required for immune down-modulation of chronic disease Journal of Immunology 1998 160 9 4473 4480 (Pubitemid 28217306)
37. Todt J. C., Whitfield J. R., Ivard S. R., Boros D. L., Down-regulation of interleukin-12, interleukin-12r expression/ activity mediates the switch from Th1 to Th2 granuloma response during murine Schistosomiasis mansoni Scandinavian Journal of Immunology 2000 52 4 385 392
38. Hoffmann K. F., Cheever A. W., Wynn T. A., IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis Journal of Immunology 2000 164 12 6406 6416 (Pubitemid 30408823)
39. Nyame A. K., Lewis F. A., Doughty B. L., Correa-Oliveira R., Cummings R. D., Immunity to schistosomiasis: glycans are potential antigenic targets for immune intervention Experimental Parasitology 2003 104 1-2 1 13 (Pubitemid 41123180)